EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Feathered bioreactor: transforming a chicken egg into a recombinant protein biomanufacturing foundry

Adnan Naim, Arjun Sharma, Sanket Kumar Ray, Debasis Nayak

Poultry Science · 2026-12 · 105 (12) · 107751

DOI: 10.1016/j.psj.2026.107751 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Poultry Science, 2026-12. Verfasst von Adnan Naim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Bypass Road, Bhauri, Madhya Pradesh, 462066, In…. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Institute of Science Education and Research Bhopal, Anusandhan National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limitations of conventional small-molecule drugs in treating complex chronic and inherited disorders have driven demand for recombinant protein therapeutics offering superior target specificity and mechanistic precision. However, existing production platforms remain inadequate: bacterial systems lack post-translational processing machinery; yeast and insect systems produce non-human glycans; and mammalian cell-based systems, while biologically capable, require infrastructure that renders therapeutics inaccessible in resource-limited settings. This review examines the transgenic chicken egg as a compelling manufacturing alternative, whose oviduct epithelium can be reprogrammed through Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9 (CRISPR/Cas9) mediated primordial germ cell editing to secrete recombinant proteins directly into albumen at clinically meaningful yields. The chicken egg's predominant human-compatible N-acetylneuraminic acid (Neu5Ac) glycosylation, natural sterility, and simplified protein matrix collectively address the biological and economic shortcomings of conventional platforms. Regulatory approval of egg-derived biopharmaceuticals, including Kanuma and Epovet, validates this approach. Outstanding challenges, including incomplete sialylation and extended flock-establishment timelines, are critically discussed, along with strategies to overcome them.

Schlagwörter

Stichwörter der Autor:innen

BiomanufacturingBioreactorChicken eggPrimordial germ cellRecombinant protein

Autor:innen und Institutionen

  • Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Bypass Road, Bhauri, Madhya Pradesh, 462066, India.
  • Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Bypass Road, Bhauri, Madhya Pradesh, 462066, India. Electronic address: debasis@iiserb.ac.in.

Förderung

  • Indian Institute of Science Education and Research Bhopal
  • Anusandhan National Research Foundation

Zitieren

APA

Naim, A., Sharma, A., Ray, S. K., & Nayak, D. (2026). Feathered bioreactor: transforming a chicken egg into a recombinant protein biomanufacturing foundry. Poultry Science, 105(12), 107751. https://doi.org/10.1016/j.psj.2026.107751

Vancouver

Naim A, Sharma A, Ray SK, Nayak D. Feathered bioreactor: transforming a chicken egg into a recombinant protein biomanufacturing foundry. Poultry Science. 2026;105(12):107751. doi:10.1016/j.psj.2026.107751

BibTeX
@article{Naim2026,
  author = {Naim, Adnan and Sharma, Arjun and Ray, Sanket Kumar and Nayak, Debasis},
  title = {Feathered bioreactor: transforming a chicken egg into a recombinant protein biomanufacturing foundry},
  journal = {Poultry Science},
  year = {2026},
  volume = {105},
  number = {12},
  pages = {107751},
  doi = {10.1016/j.psj.2026.107751}
}
Kostenlos starten →